The Japanese drugmaker said that interim results from the 530-patient VISIONARY study showed that sibeprenlimab achieved a ...

To learn more about the true value of AI and GenAI in pharma, pharmaphorum spoke with Sudip Chakraborty, Principal and Head ...

In 2018, the EEA accounted for 18% and China made up around 9%, with the massive increase in the latter in a few short years ...

Earlier this month, Sanofi revealed talks were ongoing with CD&R, and has now confirmed the negotiations could result in the ...

AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with ...

Boston-based Seaport said the money would support a pipeline of improved neuropsychiatric drug candidates led by SPT-300, an ...

Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizer’s once-daily oral therapy Velsipity, after NICE recommended its use by the NHS. The new ...

Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life ...

ABPI partnerships director Brian Duggan considers the role that partnerships with industry have played in the last 75 years of the NHS, and how those partnerships can help the NHS face the future.

Artificial intelligence (AI) is poised to transform Medical Communications. From content creation to data analysis, AI has the potential to greatly enhance productivity and insights generation ...

NHS England has awarded a new contract to US data analytics company Palantir to transition existing NHS projects into a new federated data platform (FDP), prompting pushback from organisations ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...